NCT05064787: Evaluating the Feasibility of a Digital Health Coaching Program Post CART
Updated: Jul 2, 2022
NCT05064787: Evaluating the Feasibility of a Digital Health Coaching Program for Individuals Following CAR T Therapy
The aim of this study is to evaluate the feasibility of a digital health coaching program for, and to describe quality of life of, individuals in the 6 months following chimeric antigen receptor (CAR) T cell therapy. Up to 50 English-speaking individuals aged 18 and older who are to receive treatment with a CAR T cell therapy will be enrolled, all at The University of Texas MD Anderson Cancer Center. Participants must have internet access via smart phone, tablet, a computer, or another device with the capacity to receive calls, texts, or e-mails, as well as the electronic study assessments and will be excluded if they are unable to provide informed consent or have a prognosis of 6 months or less.
Sponsor
Collaborators
M.D. Anderson Cancer Center
Bristol-Myers Squibb
Lymphoma
Lymphoma B-Cell
Leukemia
Multiple Myeloma
Mantle Cell Lymphoma
Follicular Lymphoma
Leukemia, Acute Lymphoblastic
ClinicalTrials.gov Identifier: NCT05064787
Evaluating the Feasibility of a Digital Health Coaching Program for Individuals Following CAR T Therapy
First Posted : October 1, 2021
Click here for details on ClinicalTrials.gov
Behavioral: Digital Health Coaching
- Texas: The University of Texas MD Anderson Cancer Center Houston
Location
United States, Texas